MPT51 and MPT64-based antigen detection assay for the diagnosis of extrapulmonary tuberculosis from urine samples

Abstract

In view of WHO's “End-TB” strategy, we developed a non-invasive, urine-based ELISA, targeting 2 Mycobacterium tuberculosis antigens namely MPT51 and MPT64 for extrapulmonary TB (EPTB) diagnosis. Suspected EPTB patients (n = 137) [Pleural TB, Abdominal TB and Tuberculous meningitis] were categorized in “Definite” EPTB (n = 10) [Xpert-MTB/RIF and/or culture-positive], “Probable” EPTB (n = 77) and “Non-EPTB” (n = 50) groups using defined composite reference standards. ROC-curves were generated using ELISA results of “Definite” EPTB and “Non-EPTB” groups for both antigens independently and cut-off values were selected to provide 86.3% (95%CI:73.3–94.2) specificity for MPT51 and 92% (95%CI:80.8–97.8) for MPT64. The sensitivity of MPT51-ELISA and MPT64-ELISA was 70% (95%CI:34.7–93.3) and 90% (95%CI:55.5–99.7) for “Definite” EPTB group and 32.5% (95%CI:22.2–44.1) and 30.8% (95%CI:20.8–42.2) for “Probable” EPTB group, respectively. Combining the results of both ELISAs showed a 100% (95%CI:69.1–100) sensitivity in “Definite” EPTB group and 41.6% (95%CI:30.4–53.4) in “Probable” EPTB group, with an 80% (95%CI:66.3–89.9) specificity. The results demonstrated the potential of urine-based ELISAs as screening tests for EPTB diagnosis.